Variant report
Variant | esv3397167 |
---|---|
Chromosome Location | chr19:40174681-40175256 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:16)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:16 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr19:40174793-40175365 | Hela-S3 | cervix: | n/a | n/a |
2 | EP300 | chr19:40174929-40175340 | Hela-S3 | cervix: | n/a | n/a |
3 | FOS | chr19:40174982-40175233 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | FOS | chr19:40174937-40175231 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | FOS | chr19:40174937-40175213 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | FOS | chr19:40174921-40175246 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | FOSL2 | chr19:40174885-40175223 | HepG2 | liver: | n/a | n/a |
8 | JUN | chr19:40174888-40175347 | Hela-S3 | cervix: | n/a | n/a |
9 | JUN | chr19:40174968-40175168 | HepG2 | liver: | n/a | n/a |
10 | JUND | chr19:40174980-40175189 | H1-hESC | embryonic stem cell: | n/a | chr19:40175084-40175095 |
11 | JUND | chr19:40174942-40175239 | HepG2 | liver: | n/a | chr19:40175084-40175095 |
12 | JUND | chr19:40174866-40175308 | Hela-S3 | cervix: | n/a | chr19:40175084-40175095 |
13 | RAD21 | chr19:40174954-40175310 | Hela-S3 | cervix: | n/a | n/a |
14 | RCOR1 | chr19:40174885-40175339 | Hela-S3 | cervix: | n/a | n/a |
15 | RFX5 | chr19:40174864-40175282 | Hela-S3 | cervix: | n/a | n/a |
16 | TCF7L2 | chr19:40174921-40175297 | Hela-S3 | cervix: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000269460 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7259169 | chr19:40174688-40174689 | Weak transcription Enhancers Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs7259291 | chr19:40174710-40174711 | Weak transcription Enhancers Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs555688568 | chr19:40174753-40174754 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs146214107 | chr19:40174765-40174766 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs544814024 | chr19:40174785-40174786 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs45623444 | chr19:40174808-40174809 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs59155776 | chr19:40174870-40174871 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs142817450 | chr19:40174874-40174875 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs564823415 | chr19:40174923-40174924 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs539043249 | chr19:40174924-40174925 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs186650726 | chr19:40174926-40174927 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs192335692 | chr19:40174928-40174929 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs146945543 | chr19:40174929-40174930 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs560817823 | chr19:40174934-40174935 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs183424531 | chr19:40174960-40174961 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs531432642 | chr19:40174988-40174989 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs549550718 | chr19:40175011-40175012 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs571226251 | chr19:40175021-40175022 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs550548503 | chr19:40175024-40175025 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs138025350 | chr19:40175038-40175039 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs149494590 | chr19:40175083-40175084 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs566820566 | chr19:40175101-40175102 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs533928917 | chr19:40175111-40175112 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs188362738 | chr19:40175112-40175113 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs143871623 | chr19:40175139-40175140 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs566222875 | chr19:40175186-40175187 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs73557810 | chr19:40175196-40175197 | Enhancers Weak transcription Strong transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs568765450 | chr19:40175200-40175201 | Enhancers Weak transcription Strong transcription Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs578255261 | chr19:40175218-40175219 | Enhancers Weak transcription Strong transcription Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs148619356 | chr19:40175240-40175241 | Enhancers Weak transcription Strong transcription Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs376349104 | chr19:40175244-40175245 | Enhancers Weak transcription Strong transcription Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs559901371 | chr19:40175251-40175252 | Enhancers Weak transcription Strong transcription Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 22495311 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21364760 | CNVD |
Invasive pancreatic ductal carcinoma | 18765526 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Wilms tumour | 21544195 | CNVD |
Mental retardation | 19951919 | CNVD |
19q13.11 deletion syndrome | 22378287 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Lung cancer | 21569311 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Breast cancer | 20409316 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:40170000-40184600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr19:40171200-40189000 | Weak transcription | Psoas Muscle | Psoas |
3 | chr19:40171800-40177600 | Weak transcription | Fetal Muscle Leg | muscle |
4 | chr19:40172400-40180400 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
5 | chr19:40173200-40175800 | Strong transcription | GM12878-XiMat | blood |
6 | chr19:40174400-40177200 | Enhancers | Placenta | Placenta |
7 | chr19:40174800-40175200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
8 | chr19:40174800-40175800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr19:40175200-40175400 | Bivalent Enhancer | HepG2 | liver |
10 | chr19:40175200-40175600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |